Biosig technologies, inc. appoints mr. anthony amato to position of chief executive officer, effective immediately

Westport, ct, april 30, 2024 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) or (“biosig” or "the company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced the appointment of mr. anthony amato to the position of chief executive officer (“ceo”), effective immediately.
BSGM Ratings Summary
BSGM Quant Ranking